Affiliation:
1. National Medical Research Center named after Academician E.N. Meshalkin
2. Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Sciences
Abstract
Transcatheter aortic valve replacement is an appropriate alternative to open surgery in some patients with severe aortic stenosis who have significant comorbidities and high surgical risk.Aim. To evaluate the immediate results of transcatheter aortic valve replacement in patients with severe aortic stenosis.Material and Methods. This is a retrospective study, which included 350 patients who underwent transcatheter aortic valve replacement from 2015 to 2021. Mortality, complications, clinical data, and echocardiographic parameters were assessed in the early postoperative period after the procedure.Results. The patient mean age was 75.3 ± 7.2 years. The majority of patients had intermediate surgical risk: EuroScore II of 6.7 ± 5.4 and STS-PROM score of 3.3 ± 1.9. In most cases, there was severe hypertrophy of left ventricular (LV) myocardium with an average LV myocardial mass of 330.9 ± 88.4 g. The average postprocedural pressure gradient across the aortic valve was 8.9 ± 4.4 mm Hg. The most common procedural complication was complete heart block (10%). In-hospital mortality rate was 1.7%.Conclusion. Our register demonstrated the optimal immediate clinical and echocardiographic results of transcatheter aortic valve replacement in patients with severe aortic stenosis.
Publisher
Cardiology Research Institute
Subject
Cardiology and Cardiovascular Medicine,Public Health, Environmental and Occupational Health,Radiology, Nuclear Medicine and imaging,Medicine (miscellaneous),Internal Medicine
Reference14 articles.
1. A guide to cardiovascular surgery; by ed. V.I. Burakovsky, L.A. Bockeria; 2nd ed. Moscow: Medicine; 1996:768. (In Russ.).
2. Akodad M., Schurtz G., Adda J., Leclercq F., Roubille F. Management of valvulopathies with acute severe heart failure and cardiogenic shock. Arch. Cardiovasc. Dis. 2019;112(12):773–780. DOI: 10.1016/j.acvd.2019.06.009.
3. Vahanian A., Beyersdorf F., Praz F., Milojevic M., Baldus S., Bauersachs J. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 2021;ehab395. DOI: 10.1093/eurheartj/ehab395.
4. Díez-Villanueva P., Salamanca J., Rojas A., Alfonso F. Importance of frailty and comorbidity in elderly patients with severe aortic stenosis. J. Geriatr. Cardiol. 2017;14(6):379–382. DOI: 10.11909/j.issn.1671-5411.2017.06.005.
5. Zubarev D.D., Kretov E.I., Khelimskiy D.A., Naidenov R.A., Biryucov A.V., Prokhorikhin A.A. et al. Results of one-stage intervention in patients with concomitant coronary artery disease and aortic valve stenosis. Circulation Pathology and Cardiac Surgery. 2016;20(3):31–41 (In Russ.). DOI: 10.21688-1681-3472-2016-3-31-41.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献